Extended interval tarlatamab dosing shows consistent clinical activity in previously treated SCLC

Zoldonrasib plus daraxonrasib targets KRAS G12D in metastatic pancreatic cancer with promising early results

The impact of disease burden: Understanding patient priorities in aRCC

Therapeutic mammoplasty: An advanced oncoplastic breast surgery technique

The evolving treatment landscape in immune thrombocytopenia

Highlights from APCCC 2026

ASCO 2026: Updates in testicular, germ cell and rare genitourinary cancer

Gabapentin plus tramadol reduces opioid escalation for mucositis pain in head & neck cancer

Understanding patient expectations and clinicians' goals in favourable risk aRCC patients

Sacituzumab govitecan plus pembrolizumab improves PFS across biomarker subgroups in metastatic triple-negative breast cancer

1: Safe administration and dosing of EGFR inhibitors in NSCLC - Practical guidance for oncology nurses

2: Managing EGFR inhibitor side effects in NSCLC - Skin toxicity impact, adherence challenges, and nursing management